As part of CISCRP’s ever-growing mass media campaign, The National Clinical Trial Outreach and Awareness Initiative, we published our most recent clinical trial-focused USA Today supplement on December 7th. This initiative falls under our renowned Medical Heroes Campaign, a public service movement dedicated to engaging the public in thinking differently about clinical research. The supplement reached over one million Americans through both print and digital platforms, educating them about the importance of clinical trials and promoting greater awareness of clinical research. Key print markets included New York, Chicago, Philadelphia, Phoenix, Houston, and Seattle, with a combined readership of 750,000 print readers in combination with our digital reach of over 1,000,000 readers.
Our most recent supplement contained a variety of informational articles and educational advertisements from organizations in the clinical research industry. Merck, Transcelerate, Eli Lilly, and Pfizer were among the major contributors to the supplement, providing content and valuable insight into recent trends surrounding patient engagement and advocacy.
We had a special opportunity to include a few CISCRP-focused articles highlighting the work of our Research Services Department, as well as announcing the release of the second edition of The Gift of Participation. This helpful book is written by our founder, Ken Getz, and will be published in the coming months. With these articles, we hope to bring visibility to the important services that we offer and make the most up-to-date information about clinical research available to the public.
We also included an advertisement thanking and honoring Medical Heroes who have given the gift of their participation in clinical trials to improve public health for all people. Supporting this important message were organizations including Bristol-Myers Squibb, Janssen, Otsuka, Segal Trials, Biogen, Parexel, Allergan, UCB, Praxis, and EMD Serono.
Our feature story centered on Rachel Petties and her daughter, Alani, who is diagnosed with a rare genetic disorder called congenital, generalized lipodystrophy. Alani bravely battles this disease, which is characterized by total loss of necessary body fat tissues and abnormal storage of fat in various other areas of the body including major organs. She is currently enrolled in a long-term clinical trial program at the National Institute of Health aimed at finding ways to pre-screen for the disease, while identifying and addressing complications earlier on. The story also provided a glimpse into her mother, Rachel’s, everyday life advocating for her daughter and maintaining an inspiring level of commitment to finding a cure.
We will be publishing our next clinical trials supplement in June of 2019. There will be opportunities for sponsoring companies to contribute advertisements and/or editorial content. Contact Kat Marriott, email@example.com, for sponsorship options and for the chance to take part in the development of this next educational supplement.
Written by Katherine Marriott, Marketing & Communications Coordinator